'Arc' p11 Searchterm 'Arc' found in 67 articles 1 term [ • ] - 66 definitions [• ] Result Pages : •
Sonazoid™ is an ultrasound contrast agent (UCA) consisting of stabilized gas microbubbles in an aqueous suspension. Sonazoid™ has overcome the stability problems of first generation USCA and can produce myocardial perfusion images. Myocardial imaging using ultrasound contrast agents provides diagnosis of chronic heart disease and assessment of the coronary arteries and of the coronary blood flow reserve.
Sonazoid™ is taken up by healthy Kupffer cells in the liver and spleen, but break down in high amplitude ultrasound imaging modes such as color Doppler imaging. The bubble rupture produces a transient pressure wave, which results in a characteristic mosaic color pattern from tissues containing the microbubbles (induced acoustic emission). Liver tumors without Kupffer cells will not display the mosaic pattern and can therefore be identified easily.
Drug Information and Specification
RESEARCH NAME
NC100100
DEVELOPER
INDICATION -
DEVELOPMENT STAGE Development in USA and EU suspended
APPLICATION
-
TYPE
Microbubble
Lipid Stabilized (not disclosed)
CHARGE
Negative
Perfluorobutane
MICROBUBBLE SIZE
-
PRESENTATION
-
STORAGE
-
PREPARATION
Reconstitute with 2mL water
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE
NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT! •
SonoGen (QW7437) is an anionically charged 2% perfluorocarbon emulsion under development as a transpulmonary myocardial ultrasound contrast agent (UCA). The SonoGen microbubbles have a reduced adherence to the negatively charged vascular endothelium and reduced coalescence. SonoGen, a second generation USCA has the theoretical potential to provide high safety and efficacy and improved tissue grayscale persistence compared to first generation fluorocarbon contrast agents.
Drug Information and Specification
RESEARCH NAME
DEVELOPER
INDICATION -
DEVELOPMENT STAGE Echocardiography - Phase 1
APPLICATION
Intravenous injection
TYPE
Microbubble
Surfactant
CHARGE
Negative
Dodecafluoropentane
MICROBUBBLE SIZE
-
PREPARATION
-
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE
NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT! •
From Bracco Diagnostics, Inc.
SonoVue® was first launched in October 2001 and is now available in all European countries. SonoVue is a second generation USCA, designed and optimized with regard to the resistance to pressure. SonoVue is an example of an important family of microbubbles whose membrane consists of phospholipids. SonoVue microbubbles are filled with sulfur hexafluoride (SF6), a gas which has a low solubility and diffuses slowly in blood for the gaseous phase of the microbubbles. In particular, the SonoVue microbubbles, thanks to the high flexibility of their shell, are strongly echogenic in a wide range of frequencies and acoustic pressure and therefore can be used with both destructive and conservative contrast bubble specific imaging methods. See also Coherent Contrast Imaging.
Drug Information and Specification
RESEARCH NAME
BR1
DEVELOPER
INDICATION -
DEVELOPMENT STAGE Contrast enhanced ultrasound -
for sale APPLICATION
Intravenous
TYPE
Microbubble
Lipids: Macrogol 4000, DSPC, DPPG, Palmitic acid
CHARGE
Negative
Sulfurhexafluoride
MICROBUBBLE SIZE
99% < 11μm
PRESENTATION
Presentation 01(with integral Bio-Set transfer system) -25 mg of dry, lyophilized powder in an atmosphere of sulphur hexafluoride in a colorless Type I glass vial, with elastomeric closure and integral transfer system.Type I glass pre-filled syringe containing 5 ml sodium chloride 0.9%w/v solution for injection. - Presentation 02 (with separate MiniSpike transfer system)
STORAGE
No special precautions for storage
PREPARATION
Reconstitute with 5 ml saline
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE
NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!
Distribution Information
TERRITORY
DISTRIBUTOR
USA, EU
•
From Bayer Schering Pharma AG:
Sonovist® (sometimes found as Sonavist) is an investigational ultrasound contrast agent with a biodegradable synthetic capsule filled with sulphur hexafluoride. The biodegradable shell of Sonovist is so stable that it can be taken up by Kupffer cells of the reticuloendothelial system or accumulate in the sinusoids. Therefore, Sonovist® has an additional hepato-splenic parenchymal phase following the blood pool phase, analog to the superparamagnetic iron oxide agents used in liver MRI. The microbubbles are stationary in this phase and generate no conventional Doppler signals. This tissue-specific phase has a variable duration and can be imaged by bubble specific imaging modes.
Drug Information and Specification
RESEARCH NAME
SHU 563A
DEVELOPER
INDICATION
APPLICATION
Intravenous
TYPE
Microbubble
Cyanoacrylate (polymer sheIl)
CHARGE
-
Sulphur hexafluoride
MICROBUBBLE SIZE
-
PRESENTATION
-
STORAGE
-
PREPARATION
-
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE
NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT! •
Stress echocardiograms are used for detection of coronary artery disease, or to determine the cardiac performance. Stress echocardiograms are less performed to evaluate pulmonary artery pressures, pulmonary hypertension or the significance of valvular heart disease. Stress increases the degree to which the heart contracts. After a myocardial infarction there will be a region of the heart muscle that contracts abnormal at rest. This area may worsen with stress. A coronary artery blockage most often do not impairs the function of the heart at rest. With stress, a region of the heart does not receive enough blood to work effectively and wall motion abnormalities occur. The echocardiographer compares rest and exercise and can determine the presence and severity of a coronary artery blockage. Stress echocardiograms involve: A bicycle stress echocardiogram involves transthoracic echocardiography performed at the rest baseline and after or during different stages of physical exercise. A dobutamine stress echocardiography uses the drug dobutamine instead physical exercise. Transthoracic echocardiograms are routinely performed during stress and rest. Cardiovascular stress represents a minimal risk to the patient. See also Transesophageal Echocardiography, Echocardiography, M-Mode, Curved Transducer, Doppler Ultrasound, History of Ultrasound and History of Ultrasound Contrast Agents. Further Reading: News & More: Result Pages : |